 SOUTH SAN FRANCISCO, Calif., Jan. 10, 2022 PRNewswire -- Rigel Pharmaceuticals, Inc. Nasdaq: RIGL today announced that Raul Rodriguez, the companys president and chief executive officer, is scheduled to present a company overview at the 40th Annual J.P. 